The Greenrose Holding Co (GNRS)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Greenrose Cash from Financing (TTM): -2.681M for Sept. 30, 2022
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | -2.681M |
| June 30, 2022 | -7.65M |
| March 31, 2022 | -5.005M |
| September 30, 2021 | -197.57M |
| Date | Value |
|---|---|
| June 30, 2021 | -196.12M |
| March 31, 2021 | -193.79M |
| December 31, 2020 | -20.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-197.57M
Minimum
Sep 2021
-2.681M
Maximum
Sep 2022
-88.97M
Average
-20.00M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
| Medite Cancer Diagnostics Inc | 2.623M |
| Sunridge International Inc | -- |
| Viveve Medical Inc | 0.069M |
| Minerva Surgical Inc | 26.86M |
| CRAFT 1861 Global Holdings Inc | -14.49M |